Lithium augmentation of antidepressants in treatment-refractory depression

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 6, 1998, Pages 28-34

  Heit, Stacey ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADINAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; BROFAROMINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DIBENZEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; IPRINDOLE; LITHIUM; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGING; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; ELECTROCONVULSIVE THERAPY; HUMAN; METHODOLOGY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC TRANSMISSION;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0031809665     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Nemeroff CB. Augmentation strategies in patients with refractory depression. Depression 1997;4:169-181
2. Sangdee C, Franz DN. Lithium enhancement of central 5-HT transmission induced by 5-HT precursors. Biol Psychiatry 1980;15:59-75
3. Broderick P, Lynch V. Behavioral and biochemical changes induced by lithium and L-tryptophan in muricidal rats. Neuropharmacology 1982;21: 671-679
4. Treiser SL, Cascio CS, O'Donahue TL, et al. Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science 1981;213:1529-1531
5. de Montigny C, Aghajanian GK. Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: a comparative iontophoretic study with LSD and serotonin. Neuropharmacology 1977;16:811-818
6. de Montigny C, Grunberg F, Mayer A, et al. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 1981;138:252-256
7. Glue PW, Cowen PJ, Nutt DJ. The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors. Psychopharmacology 1986;90:398-402
8. Cowen PJ, McCance SL, Ware CJ, et al. Lithium in tricyclic-resistant depression: correlation of increased brain 5HT function with clinical outcome. Br J Psychiatry 1991;159:341-346
9. de Montigny C, Cournoyer G, Morissette R, et al. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression: correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. Arch Gen Psychiatry 1983;40:1327-1334
10. Heninger GR, Charney DS, Sternberg DE. Lithium carbonate augmentation of antidepressant treatment. Arch Gen Psychiatry 1983;40:1335-1342
11. de Montigny C, Elie R, Caille G. Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study. Am J Psychiatry 1985;142:220-223
12. Price LH, Charney DS, Heninger GR. Variability of response to lithium augmentation in refractory depression. Am J Psychiatry 1986;143: 1387-1392
13. Kantor D, McNevin S, Leichner P, et al. The benefit of lithium carbonate adjunct in refractory depression - fact or fiction? Can J Psychiatry 1986; 31:416-418
14. Zusky PM, Biederman J, Rosenbaum JF, et al. Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. J Clin Psychopharmacol 1988;8:120-124
15. Schopf J, Baumann P, Lemarchand T, et al. Treatment of endogenous depressions resistant to tricyclic antidepressants of related drugs by lithium addition: results of a placebo-controlled double-blind study. Pharmacopsychiatry 1989;22:183-187
16. Dinan TG, Barry S. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 1989;80:97-100
17. Fontaine R, Ontiveros A, Elie R, et al. Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression. Biol Psychiatry 1991; 29:946-948
18. Stein G, Bernadt B. Lithium augmentation therapy in tricyclic-resistant depression. Br J Psychiatry 1993;162:634-640
19. Dinan TG. Lithium augmentation in sertraline-resistant depression: a preliminary dose-response study. Acta Psychiatr Scand 1993;88:300-301
20. Joffe RT, Singer W, Levitt AJ, et al. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 1993;50:387-393
21. Hoencamp E, Haffmans PMJ, Dijken WA, et al. Brofaromine versus lithium addition to maprotiline: a double-blind study in maprotiline refractory depressed outpatients. J Affect Disord 1994;30:219-227
22. Fava M, Rosenbaum JF, McGrath PJ, et al. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry 1994;151:1372-1374
23. Katona CLE, Abou-Saleh MT, Harrison DA, et al. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 1995;166:80-86
24. Baumann P, Nil R, Souche A, et al. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation. J Clin Psychopharmacol 1996;16:307-314
25. Depression Guideline Panel. Depression in Primary Care, vol 2. Treatment of Major Depression: Clinical Practice Guideline, no 5. Rockville, Md: US Dept Health and Human Services, Public Health Service, Agency for Health Care Policy and Research publication no. 93-0551, April 1993
26. Stassen HH, Angst J, Delini-Stula A. Severity at baseline and onset of improvement in depression: meta-analysis of imipramine and moclobemide versus placebo. European Journal of Psychiatry 1994;9:129-136
27. Austin MPV, Souza FGM, Goodwin GM. Lithium augmentation in antidepressant-resistant patients: a quantitative analysis. Br J Psychiatry 1991; 159:510-514
28. Camprubi ME, Puri BK. The treatment of refractory depression using paroxetine with lithium augmentation. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:515-517
29. Louie AK, Meltzer HY. Lithium potentiation of antidepressant treatment. J Clin Psychopharmacol 1984;4:316-321
30. Nelson JC, Byck R. Rapid response to lithium in phenelzine nonresponders. Br J Psychiatry 1982;141:85-86
31. Birkhimer LJ, Alderman AA, Schmitt CE, et al. Combined trazodone-lithium therapy for refractory depression. Am J Psychiatry 1983;140: 1382-1383
32. Nierenberg AA, Price LH, Chamey DS, et al. After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression. J Affect Disord 1990;18:167-175
33. Flint AJ, Rifat SL. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 1994;14: 353-356
34. Price LH, Conwell Y, Nelson JC. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry 1983;140:318-322
35. van Marwijk HWJ, Bekker FM, Nolen WA, et al. Lithium augmentation in geriatric depression. J Affect Disord 1990;20:217-223
36. Salama AA, Shafey M. A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate [letter]. Am J Psychiatry 1989; 146:278